Found: 15
Select item for more details and to access through your institution.
Treatment of Post-transplant Relapse of FLT3-ITD Mutated AML Using 5-Azacytidine and Sorafenib Bitherapy.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Venetoclax‐based non‐intensive induction followed by allogenic stem‐cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 6, p. 751, doi. 10.1111/ejh.14290
- By:
- Publication type:
- Article
Saprochaete clavata Outbreak Infecting Cancer Center through Dishwasher.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Disseminated Scedosporium Invasive Fungal Infection in Critically ill Newly Diagnosed Acute Myeloid Leukemia Patient Complicated with Cerebritis.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23376-6
- By:
- Publication type:
- Article
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 2025, doi. 10.3390/cancers14082025
- By:
- Publication type:
- Article
Alternative Effective and Safe Induction Regimens for Newly Diagnosed Acute Myeloid Leukemia in Patients With Cardiac Contraindication to Anthracyclines.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Topotecan Plus Cytarabine: An Effective and Safe Induction Regimen for Newly Diagnosed Acute Myeloid Leukemia in Patients with Cardiac Contra-Indication to Anthracyclines.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S214, doi. 10.1016/j.clml.2019.07.083
- By:
- Publication type:
- Article
Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells.
- Published in:
- Frontiers in Immunology, 2017, v. 8, p. 1, doi. 10.3389/fimmu.2017.00064
- By:
- Publication type:
- Article
Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. 330, doi. 10.1002/ajh.24973
- By:
- Publication type:
- Article
Comparison of 60 or 90 mg/m<sup>2</sup> of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 2, p. E29, doi. 10.1002/ajh.23884
- By:
- Publication type:
- Article
Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 1, p. E22, doi. 10.1002/ajh.23850
- By:
- Publication type:
- Article
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 1, p. 83, doi. 10.1002/ajh.23592
- By:
- Publication type:
- Article
Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 5, p. 974, doi. 10.1002/cncr.25554
- By:
- Publication type:
- Article